Topic: Radical treatment of low- and intermediate-risk PCa
Case 1: Adam (63 years old)
Adam, a 63-year-old concierge of a university, was recently diagnosed with localised PCa.
Summary of diagnostic findings:
PSA: 6.0 ng/mL
Prostate biopsy: 2/12 positive cores, Gleason score (GS) 3+3 (ISUP grade 1)
Clinical stage: cT2a
MRI findings: no tumour visible
What is the most appropriate treatment choice for this patient?